Eyes On Eyecare

Bausch + Lomb Corporation (B+L) is?introducing its latest addition?to the U.S. commercial market: Arise, a cloud-based orthokeratology (ortho-k) lens fitting system. Learn more on Glance: https://lnkd.in/eyNEnfZz #GlanceNews #eyecare Brent Saunders

Are you struggling with dry eye and ocular surface disease in your practice? Learn how the OMNICAD? by Lumibird Medical is helping doctors improve clinical decision making in diagnosing and creating more personalized treatment plans. Get started: https://hubs.ly/Q03cLV7X0 #eyecare

Aimée McBride, OD, and Tommy Pinkston, OD, found more than just a career in rural optometry—they built lasting patient relationships and a thriving practice. With support from Vision Source, they’re making the most of small-town life. Discover how their approach has led to success—watch their story and get the free guide to learn more about practicing in a rural setting! https://hubs.ly/Q03cCVYG0 #optometrist #optometry #eyecare

ANI Pharmaceuticals, Inc. has?received FDA approval for an expanded label?of ILUVIEN (fluocinolone acetonide intravitreal implant) 0.19 mg for the treatment of chronic non-infectious uveitis (NIU) affecting the posterior segment of the eye (NIU-PS). This marks the second ophthalmic approval for the company since its?September 2024 acquisition?of Alimera Sciences, Inc.—with the first (Purified Cortrophin Gel PFS) secured earlier this month. Learn more on Glance: https://hubs.ly/Q03cBSpN0 #GlanceNews #FDA #eyecare Kevin Chan

Could fewer injections lead to the same results? Retina specialists, John W. Kitchens, MD, and Michael Klufas, MD break down the latest clinical data on second-generation anti-VEGFs and their impact on treatment strategies. Watch here: https://hubs.ly/Q03cm34p0

Discover what Omar Shakir, MD, MBA, and Seth Pantanelli, MD, MS, had to say about the QUATERA 700 and MICOR 700, at the 5th Ophthalmic Medical Education Summit. Learn how it has revolutionized their approach to lens extraction and enhanced their outcomes. https://hubs.ly/Q03bt-1y0 #eyecare?

The FDA has granted Fast Track designation to Atsena Therapeutics’ gene therapy candidate for X-linked retinoschisis (XLRS): ATSN-201. Learn more on Glance: https://hubs.ly/Q03bYNN90 #GlanceNews Patrick Ritschel

Amidst the backdrop of an ever-changing landscape of new tariffs impacting the United States economy over the last few weeks—including a new round that took effect on March 12—The Vision Council (TVC) recently?hosted a webinar?to discuss the potentially significant implications the optical industry may face as a result. But before we get to that, here’s a rundown on the timeline of these U.S.-imposed tariffs (otherwise known as taxes on imports). Learn more on Glance: https://lnkd.in/eSayAYcC #GlanceNews #tariffs Kayleigh Tokash

Sydnexis, Inc. has?received FDA acceptance?for its new drug application (NDA) of SYD-101, a proprietary formulation under clinical development for the treatment of pediatric myopia progression. Learn more on Glance: https://lnkd.in/eC95J9jD #GlanceNews Patrick Johnson

ZEISS Professional Education partnered with Eyes On Eyecare for the 5th Ophthalmic Medical Education Summit in August 2024. Discover what Dr. John Doane, MD, FACS, Sidney Gicheru, MD, and Bruce Rivers, MD, had to say about SMILE with the ZEISS VISUMAX 800, including case studies on efficiency, outcomes, and recovery. https://hubs.ly/Q039PC6H0 #eyecare?